<DOC>
	<DOCNO>NCT02153125</DOCNO>
	<brief_summary>The aim study determine efficacy safety treat patient chronic central serous chorioretinopathy drug eplerenone .</brief_summary>
	<brief_title>Eplerenone For Treatment Chronic Central Serous Chorioretinopathy</brief_title>
	<detailed_description>- The goal study examine short-term effect safety eplerenone , systemic anti-aldosterone medication , group patient central serous chorioretinopathy ( CSCR ) . - There currently standard treatment therapy chronic CSCR , potentially debilitate eye disease . - There evidence high blood serum corticosteroid level cause worsen CSCR - Eplerenone , mineralocorticoid receptor antagonist , show visual anatomic benefit small series 4 patient chronic CSCR , suggest decrease mineralocorticoid action eye may improve sign symptom CSCR - The study 's aim evaluate standardize dose eplerenone control prospective fashion chronic CSCR . - The study consist take standard dose eplerenone , 25mg daily week , follow 50mg daily , total 3 month - Patients monitor efficacy side effect begin treatment 6 month</detailed_description>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Chronic central serous chorioretinopathy ( CSCR ) : Previous diagnosis CSCR , persistent subretinal fluid OCT 4 month initial presentation eye clinic Other retinal disease Choroidal neovascularization Diabetes A history uveitis Ocular surgery prior 3 month Allergy fluorescein indocyanine green Pregnancy , lactation female patient fertility age treat contraceptive pill Creatinine clearance &lt; 50 ml/min Hyperkalemia &gt; 5 mmol/l Patients treat drug deactivate cytochrome P450 3A4 ( CYP3A4 ) Serum creatinine &gt; 2 mg/dl men &gt; 1.8 mg/dl woman Treatment potassium spar agent potassium Treatment Angiotensin convert enzyme ( ACE ) /angiotensin II receptor blocker ( ARB ) inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>